Concepedia

Publication | Open Access

Phase I dose-escalation study of AZD7762, a checkpoint kinase inhibitor, in combination with gemcitabine in US patients with advanced solid tumors

DOIFull Paper Access

195

Citations

22

References

2014

Year

Edward A. Sausville, Patricia LoRusso, Michael A. Carducci, Judith Carter, Mary Flanagan Quinn, Lisa Malburg, Nilofer S. Azad, David Cosgrove, Richard Knight, Peter Barker,
Cancer Chemotherapy and Pharmacology

References

YearCitations

Page 1